(Q44513000)

3 December 2017

title

Type II nitric oxide synthase activity is cardio-protective in experimental sepsis (English)

1 reference

3 December 2017

0 references

Suzanna Price

1

1 reference

3 December 2017

Jane A Mitchell

series ordinal

2

1 reference

3 December 2017

Peter B Anning

series ordinal

3

1 reference

3 December 2017

Timothy W Evans

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

European Journal of Pharmacology

3 December 2017

published in

1 reference

3 December 2017

volume

472

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

111-118

1 reference

Association between mitochondrial dysfunction and severity and outcome of septic shock

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Cellular Localization of Inducible Nitric Oxide Synthase in Experimental Endotoxic Shock in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Nitric oxide: a cytotoxic activated macrophage effector molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Inhibition of nitric oxide synthase as a potential therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Control of coronary vascular tone by nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Effects of nitric oxide-modulating amino acids on coronary vessels: relevance to sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Profound but reversible myocardial depression in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Effects of a nitric oxide synthase inhibitor in humans with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Myocardial dysfunction in sepsis: mechanisms and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

The nitric oxide synthase family of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

What turns on the endothelins?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901826-0

10.1016/S0014-2999(03)01826-0

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference